26 related articles for article (PubMed ID: 7665235)
1. Interferon-alpha (Intron A) upregulates urokinase-type plasminogen activator receptor gene expression.
Wu S; Murrell GA; Wang Y
Cancer Immunol Immunother; 2002 Jul; 51(5):248-54. PubMed ID: 12070711
[TBL] [Abstract][Full Text] [Related]
2. Glycosylation defining cancer malignancy: new wine in an old bottle.
Hakomori S
Proc Natl Acad Sci U S A; 2002 Aug; 99(16):10231-3. PubMed ID: 12149519
[No Abstract] [Full Text] [Related]
3. The Low FODMAP Diet and Its Application in East and Southeast Asia.
Iacovou M; Tan V; Muir JG; Gibson PR
J Neurogastroenterol Motil; 2015 Oct; 21(4):459-70. PubMed ID: 26350937
[TBL] [Abstract][Full Text] [Related]
4. Role of urokinase and its receptor in basal and stimulated colonic epithelial cell migration in vitro.
Wilson AJ; Gibson PR
Gut; 2000 Jul; 47(1):105-11. PubMed ID: 10861271
[TBL] [Abstract][Full Text] [Related]
5. Recombinant factor XIII improves established experimental colitis in rats.
D'Argenio G; Grossman A; Cosenza V; Valle ND; Mazzacca G; Bishop PD
Dig Dis Sci; 2000 May; 45(5):987-97. PubMed ID: 10795765
[TBL] [Abstract][Full Text] [Related]
6. Urokinase type plasminogen activator receptor expression in colorectal neoplasms.
Suzuki S; Hayashi Y; Wang Y; Nakamura T; Morita Y; Kawasaki K; Ohta K; Aoyama N; Kim SR; Itoh H; Kuroda Y; Doe WF
Gut; 1998 Dec; 43(6):798-805. PubMed ID: 9824607
[TBL] [Abstract][Full Text] [Related]
7. The plasminogen activator system: biology and regulation.
Irigoyen JP; Muñoz-Cánoves P; Montero L; Koziczak M; Nagamine Y
Cell Mol Life Sci; 1999 Oct; 56(1-2):104-32. PubMed ID: 11213252
[TBL] [Abstract][Full Text] [Related]
8. Butyrate and the colonocyte. Implications for neoplasia.
Velázquez OC; Lederer HM; Rombeau JL
Dig Dis Sci; 1996 Apr; 41(4):727-39. PubMed ID: 8674394
[TBL] [Abstract][Full Text] [Related]
9. Sodium butyrate differentially modulates plasminogen activator inhibitor type-1, urokinase plasminogen activator, and its receptor in a human colon carcinoma cell.
Reeder JA; Dickinson JL; Chenevix-Trench G; Antalis TM
Teratog Carcinog Mutagen; 1993; 13(2):75-88. PubMed ID: 8102211
[TBL] [Abstract][Full Text] [Related]
10. Expression of urokinase-type plasminogen activator, its receptor and type-1 plasminogen activator inhibitor is differently regulated by inhibitors of protein synthesis in human cancer cell lines.
Lund LR
FEBS Lett; 1996 Apr; 383(3):139-44. PubMed ID: 8925884
[TBL] [Abstract][Full Text] [Related]
11. Sodium butyrate inhibits expression of urokinase and its receptor mRNAs at both transcription and post-transcription levels in colon cancer cells.
Dang J; Wang Y; Doe WF
FEBS Lett; 1995 Feb; 359(2-3):147-50. PubMed ID: 7867787
[TBL] [Abstract][Full Text] [Related]
12. Sphingosine-1-phosphate and interleukin-1 independently regulate plasminogen activator inhibitor-1 and urokinase-type plasminogen activator receptor expression in glioblastoma cells: implications for invasiveness.
Bryan L; Paugh BS; Kapitonov D; Wilczynska KM; Alvarez SM; Singh SK; Milstien S; Spiegel S; Kordula T
Mol Cancer Res; 2008 Sep; 6(9):1469-77. PubMed ID: 18819934
[TBL] [Abstract][Full Text] [Related]
13. Significant down-regulation of the plasminogen activator inhibitor 1 mRNA in pancreatic cancer.
Warnecke-Eberz U; Prenzel KL; Baldus SE; Metzger R; Dienes HP; Bollschweiler E; Hoelscher AH; Schneider PM
Pancreas; 2008 Mar; 36(2):173-7. PubMed ID: 18376309
[TBL] [Abstract][Full Text] [Related]
14. Butyrate regulates gene expression of the plasminogen activating system in colon cancer cells.
Antalis TM; Reeder JA
Int J Cancer; 1995 Sep; 62(5):619-26. PubMed ID: 7665235
[TBL] [Abstract][Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
